Skip to main content
Clinical Trials/ACTRN12612001008819
ACTRN12612001008819
Not yet recruiting
Phase 3

Patients with chronic rhinosinusitis receiving intranasal mannitol powder, compared to standard medical therapies, to alleviate sinusitis symptoms.

Dr Emad Massoud0 sites40 target enrollmentSeptember 19, 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Chronic rhinosinusitis
Sponsor
Dr Emad Massoud
Enrollment
40
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 19, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Emad Massoud

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic rhinosinusitis (as defined by the Canadian clinical practice guidelines for acute and chronic sinusitis)

Exclusion Criteria

  • Previous sinus surgery
  • Allergy or sensitivity to any of the items in the standard medical treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials